Hostname: page-component-586b7cd67f-2brh9 Total loading time: 0 Render date: 2024-11-23T00:43:26.975Z Has data issue: false hasContentIssue false
  • English
  • Français

What is more important, the appropriateness or the rate of psychotropic prescription in aged care homes?

Published online by Cambridge University Press:  25 June 2021

Yun-Hee Jeon ,
Mouna Sawan ,
Judy Simpson  and
Henry Brodaty Open the ORCID record for Henry Brodaty [Opens in a new window]
Yun-Hee Jeon*
Affiliation:
The Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
Mouna Sawan
Affiliation:
The Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
Judy Simpson
Affiliation:
The Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
Henry Brodaty
Affiliation:
The University of New South Wales Australia, Kensington, Australia
*
Email: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Commentary
Information
International Psychogeriatrics , Volume 33 , Special Issue 6: Issue Theme: Diverse Strategies for Improving Seniors’ Well-Being , June 2021 , pp. 539 - 542
Copyright
© International Psychogeriatric Association 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ballard, C. etal. (2016). Impact of antipsychotic review and nonpharmacological intervention on antipsychotic use, neuropsychiatric symptoms, and mortality in people with dementia living in nursing homes: a factorial cluster-randomized controlled trial by the Well-Being and Health for People With Dementia (WHELD) Program. The American Journal of Psychiatry, 173, 252–262.CrossRefGoogle ScholarPubMed
Ballard, C. and Corbett, A. (2020). Reducing psychotropic drug use in people with dementia living in nursing homes. International Psychogeriatrics, 32, 291–294. https://doi.org/10.1017/S1041610219001455 CrossRefGoogle ScholarPubMed
Brodaty, H. etal. (2018). Antipsychotic deprescription for older adults in long-term care: the HALT study. Journal of the American Medical Directors Association, 19, 592.e597–600.e597.CrossRefGoogle ScholarPubMed
Chenoweth, L. etal. (2009). Caring for aged dementia care resident study (CADRES), a clusterrandomised trial of person-centred-care, dementia care mapping and usual care in dementia. Lancet Neurology, 8, 317–325.CrossRefGoogle Scholar
Harrison, S. L., Cations, M., Jessop, T., Hilmer, S. N., Sawan, M., & Brodaty, H. (2019). Approaches to deprescribing psychotropic medications for changed behaviours in long-term care residents living with dementia. Drugs & Aging, 36, 125–136. doi: 10.1007/s40266-018-0623-6 CrossRefGoogle ScholarPubMed
Harrison, F. etal. (2020). Prolonged use of antipsychotic medications in long-term aged care in Australia: a snapshot from the HALT project. International Psychogeriatrics, 32, 335–345. doi: 10.1017/S1041610219002011 CrossRefGoogle Scholar
Kales, H. C., Gitlin, L. N., & Lyketsos, C. G. (2015). Assessment and management of behavioral and psychological symptoms of dementia. BMJ, 350, h369 CrossRefGoogle ScholarPubMed
Muniz, R. etal. (2019). The “CHROME criteria”: tool to optimize and audit prescription quality of psychotropic medications in institutionalized people with dementia. International Psychogeriatrics, 32, 315–324.CrossRefGoogle Scholar
National Institute for Health and Care Excellence. (2018). Dementia: assessment, management and support for people living with dementia and their carers (NICE Guideline No. 97). Retrieved from https://www.nice.org.uk/guidance/ng97 Google Scholar
Sawan, M., Jeon, Y-H., and Chen, T. F. (2018). Shaping the use of psychotropic medicines in nursing homes: a qualitative study on organisational culture. Social Science & Medicine, 202, 70–78.CrossRefGoogle ScholarPubMed
Sawan, M., Jeon, Y-H., Fois, R., & Chen, T. F. (2017). Exploring the link between organizational climate and the use of psychotropic medicines in nursing homes: a qualitative study. Research in Social & Administrative Pharmacy: RSAP, 13, 513–523. doi: 10.1016/j.sapharm.2016.06.012 CrossRefGoogle ScholarPubMed
Sawan, M., Jeon, Y-H., Fois, R., and Chen, T. F. (2016). A qualitative study exploring visible components of organizational culture: what influences the use of psychotropic medicines in nursing homes? International Psychogeriatrics, 28, 1725–1735. doi: 10.1017/S1041610216000715 CrossRefGoogle ScholarPubMed
Smeets, C. H. W. etal. (2020). Can the PROPER intervention reduce psychotropic drug prescription in nursing home patients with dementia? Results of a cluster-randomized controlled trial. International Psychogeriatrics CrossRefGoogle Scholar
Thompson Coon, J. etal. (2014). Interventions to reduce inappropriate prescribing of antipsychotic medications in people with dementia resident in care homes: a systematic review. Journal of the American Medical Directors Association, 15, 706–718.CrossRefGoogle ScholarPubMed
van der Spek, K. etal. (2015). A reliable and valid index was developed to measure appropriate psychotropic drug use in dementia. Journal of Clinical Epidemiology, 68, 903–912.CrossRefGoogle ScholarPubMed
van der Spek, K. etal. (2018). The effect of biannual medication reviews on the appropriateness of psychotropic drug use for neuropsychiatric symptoms in patients with dementia: a randomised controlled trial. Age and Ageing, 47, 430–437.CrossRefGoogle ScholarPubMed
Westbury, J. etal. (2018). RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities. Medical Journal of Australia, 208, 398–403.CrossRefGoogle ScholarPubMed
Westbury, J., Tichelaar, L., Peterson, G., Gee, P. and Jackson, S. (2011). A 12-month follow-up study of “RedUSe”: a trial aimed at reducing antipsychotic and benzodiazepine use in nursing homes. International Psychogeriatrics, 23, 1260–1269.CrossRefGoogle ScholarPubMed